Amendment of Statement of Principles concerning malignant neoplasm of the lip epithelium No. 50 of 2001

Overview

The Veterans’ Entitlements Act 1986, enacted in 1986, was designed to provide various benefits and compensations to veterans and their families in Australia. A gap identified was the need to expand the scope of conditions recognised as service-related, particularly concerning malignant neoplasms. This legislative instrument, F2005B02506, specifically addresses the inclusion of malignant neoplasm of the lip epithelium as a condition warranting recognition under the Act. The Repatriation Medical Authority, acting under the authority granted by the Veterans’ Entitlements Act 1986, amended the Statement of Principles concerning malignant neoplasm of the lip epithelium to ensure that affected veterans are eligible for the appropriate benefits. The policy objective behind these amendments is to ensure that veterans suffering from specific malignant conditions receive the requisite medical and financial support.

Scope and Application

The Legislative Instrument No. 50 of 2001 amends the Statement of Principles concerning Malignant Neoplasm of the Lip Epithelium, amending Instrument No. 42 of 2001 under subsection 196B(3) of the Veterans’ Entitlements Act 1986. The amendment specifically targets the definitions of terms such as “total lifetime UV damage factor”, “non-service UV damage factor”, “[MED cum (a,T)]”, “PAE”, and “T”, by replacing references to “acquired cataract” with “malignant neoplasm of the lip epithelium”. The application of these amendments extends to all matters governed by Instrument No. 42 of 2001 and section 120B of the Veterans’ Entitlements Act 1986, thereby impacting the eligibility criteria and assessment process for veterans seeking entitlements related to malignant neoplasm of the lip epithelium. This legislative change ensures that the criteria for assessing UV damage and related entitlements now specifically consider malignant neoplasm of the lip epithelium, thereby refining the scope of the entitlements available under the Act.

Key Provisions

The key provision of this legislative instrument, under the Veterans’ Entitlements Act 1986, involves the amendment of the Statement of Principles concerning malignant neoplasm of the lip epithelium (sections 1 and 2). Specifically, this instrument removes references to "acquired cataract" and replaces them with "malignant neoplasm of the lip epithelium" in various definitions within the Act. This change applies to all matters governed by Instrument No.42 of 2001 and section 120B of the Act, ensuring consistency in the interpretation and application of the terms related to malignant neoplasm of the lip epithelium. The amendments impose specific obligations on the parties and entities governed by the Act. For example, the definitions of "total lifetime UV damage factor", "non-service UV damage factor", "[MED cum (a,T)]", "PAE", and "T" must now be interpreted in the context of malignant neoplasm of the lip epithelium. This change ensures that the assessment and evaluation of veterans' claims related to this condition are based on the correct criteria. The Repatriation Medical Authority and other relevant entities must adhere to these updated definitions when processing claims and making determinations regarding entitlements. The instrument does not explicitly detail offences, penalties, or consequences for breaches in this particular amendment. However, under the general provisions of the Veterans’ Entitlements Act 1986, breaches of the Act can lead to various civil or criminal consequences. These may include fines, imprisonment, or other penalties as prescribed by the relevant legislation. The exact penalties depend on the nature and severity of the breach, as well as any additional provisions that may be specified in other sections of the Act or related instruments.